|
|
|
| Clinical effect of Liangxue Tuibi Decoction on patients of psoriasis vulgaris with syndrome of blood heat |
| GONG Ke1 GUO Jianhui1 GUO Wen1 DU Kaiqing1 SHEN Yana2 |
1.Department of Dermatology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Hebei University of Chinese Medicine, Hebei Province, Cangzhou 061000, China;
2.Graduate School, Chengde Medical College, Hebei Province, Chengde 067000, China |
|
|
|
Abstract Objective To observe the clinical effect of Liangxue Tuibi Decoction on patients of psoriasis vulgaris with syndrome of blood heat. Methods A total of 80 patients of psoriasis vulgaris with syndrome of blood heat were treated in the Department of Dermatology, Cangzhou Hospital of Integrated traditional Chinese and Western Medicine Affiliated to Hebei University of Chinese Medicine from November 2020 to August 2021 were selected as the research object. They were divided into treatment group and control group by random number table method, 40 cases in each group. The control group was given Xiaoyin Granules, the observation group was given Liangxue Tuibi Decoction. After 8 weeks of treatment, the clinical effect was compared between the two groups, the changes in the psoriasis area and severity index (PASI) score, traditional Chinese medicine syndrome score, dermatology life quality index (DLQI) score, serum squmaous cell carcinoma antigen (SCCA) level and vascular endothelial growth factor (VEGF) level and the incidence of adverse reactions before and after treatment were observed. Results The clinical effect of the treatment group was better than that of the control group (P ＜ 0.05). After treatment, PASI scores in both groups were lower than those before treatment, and that in the treatment group was lower than that in the control group (P ＜ 0.05). After treatment, the traditional Chinese medicine syndrome scores of both groups were lower than those before treatment , and that in the treatment group was lower than that in the control group (P ＜ 0.05). After treatment, DLQI scores in both groups were lower than those before treatment, but there was no significant difference in DLQI scores between the two groups (P ＞ 0.05). After treatment, the levels of serum SCCA and VEGF in both groups were lower than those before treatment, and those in treatment group were lower than those in control group (P ＜ 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (χ2=0.2632, P = 0.6079). Conclusion Liangxue Tuibi Decoction can effectively improve the skin lesions and symptoms of psoriasis vulgaris patients with syndrome of blood heat, with obvious clinical effect and few adverse reactions, which is worthy of clinical application.
|
|
|
|
|
|
[1] 张学军.皮肤性病学[M].8版.北京：人民卫生出版社，2013：139-142.
[2] 李慧贤，胡丽，郑焱，等.基于全球疾病负担（GBD）大数据的中国银屑病流行病学负担分析[J].中国皮肤性病学杂志，2021，35（4）：386-392.
[3] 中华医学会皮肤性病学分会银屑病专业委员会.中国银屑病诊疗指南（2018完整版）[J].中华皮肤科杂志，2019， 52（10）：667-710.
[4] 曹艳红，朱珂，潘富强，等.中医治疗寻常型银屑病的证候分布及用药规律的文献分析[J].广州中医药大学学报，2020，37（6）：1198-1201.
[5] 中华中医药学会皮肤科分会.寻常型银屑病（白疕）中医药循证临床实践指南（2013版）[J].中医杂志，2014，55（1）：76-82.
[6] Watanabe Y，Yamaguchi Y，Komitsu N，et al. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis：associations with disease severity and response to the treatment [J]. Br J Dermatol，2016，174（6）：1327-1336.
[7] 任春娜，杨洪亮，沈聪，等.血清中鳞状细胞癌抗原的表达水平与银屑病活动性的相关性[J].中国医药科学，2017，7（5）：169-171.
[8] 朱峻，徐田红，沈宏，等.197例银屑病患者血清中鳞状细胞癌抗原的表达及意义[J].中国中西医结合皮肤性病学杂志，2014，13（5）：298-300.
[9] Zhang RC，Zheng NN，Zhong LS. Different expression of squamous cell carcinoma antigens in psoriasis vulgaris and other papulosquamous dermatoses [J]. Australas J Dermatol，2020，61（2）：e261-e262.
[10] 韦千里，郑妮，孙奇.寻常性银屑病患者皮损中血管内皮生长因子和环氧化物酶-2的表达及意义[J].临床皮肤科杂志，2013，42（8）：464-465.
[11] Martinez AL，Smart JH，Paus R，et al. Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis [J]. Exp Dermatol，2020，29（8）：687-698.
[12] Li W，Man XY，Chen JQ，et al. Targeting VEGF/VEGFR in the treatment of psoriasis [J]. Discov Med，2014，18（98）：97-104.
[13] 赵辩.中国临床皮肤病学[M].2版.南京：江苏凤凰科学技术出版社，2017：1108-1110.
[14] Schmitt J，Wozel G. The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis [J]. Dermatology，2005， 210（3）：194-199.
[15] 郑筱萸.中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002：299-302.
[16] Finlay AY，Khan GK. Dermatology Life Quality Index（DLQI）-a simple practical measure for routine clinical use [J]. Clin Exp Dermatol，1994，19（3）：210-216.
[17] Chen H，Lu C，Liu H，et al. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway [J]. Int Immunopharmacol，2017，48：110-117.
[8] 冉雪蓉，张堂钦，蔡一凡，等.基于文献计量法分析健康相关生命质量量表在慢性肝炎领域中的应用[J].中国全科医学，2018，21（35）：4377-4382.
[9] Han H，Qin Y，Yu Y，et al. Atrial fibrillation in hospitalized patients with end-stage liver disease： temporal trends in prevalence and outcomes [J]. Liver Int，2020，40（6）：1-2.
[10] 王秀峰，钟云青，张荣臻，等.温阳化浊退黄汤治疗乙肝相关慢加急性肝衰竭的临床研究[J].中国中医急症，2019，28（9）：42-44，48.
[11] 顾欢，芦龙青，朱英.肝硬化腹水的中医药治疗现状[J].辽宁中医杂志，2020，47（4）：217-220.
[12] 龙远雄，孙克伟，雍苏南.基于因子分析和关联规则挖掘乙型肝炎肝硬化中医用药配伍规律[J].湖南中医药大学学报，2019，39（6）：97-100.
[13] 包海蓉，徐玉萍，张晓天.中西医结合疗法联合肝病治疗仪治疗脾肾阳虚型乙型肝炎肝硬化腹水的临床研究[J].中西医结合肝病杂志，2020，30（5）：33-35.
[14] 张宁怡，韩海啸，来要水，等.寒热错杂型非糜烂性胃食管反流病经穴红外热图特征研究[J].中国中西医结合消化杂志，2019，27（9）：29-33.
[15] 吕琴，赵文晓，王世军，等.黄芪活血功效及现代药理学研究进展[J].中国实验方剂学杂志，2020，26（9）：215-224.
[16] 尚坤，李敬文，常美月，等.冰片化学成分及药理作用研究[J].吉林中医药，2018，38（1）：93-95.
[17] 郑保平，韩立民，刘海华，等.中医药治疗肝硬化腹水的组方用药规律分析[J].辽宁中医杂志，2018，45（2）：233-236.
[18] 何成邦，沈国英，孙成芝，等.茯苓桂枝白术甘草汤联合针灸及中药敷脐治疗肝硬化腹水疗效及安全性观察[J].四川中医，2018，36（11）：100-103.
[19] 万新焕，王瑜亮，周长征，等.丹参化学成分及其药理作用研究进展[J].中草药，2020，51（3）：788-798.
[20] 师帅，胡元会，吴华芹，等.“丹参-三七”药对作用机制的网络药理学探讨[J].中国实验方剂学杂志，2018，24（18）：192-197.
[21] 王轻轻，李梦云，张晓林，等.拔罐治疗儿童功能性腹痛临床疗效观察[J].广州中医药大学学报，2019，36（11）：1744-1748.
[22] 张妍，李春晖，刘蒙，等.隔药灸气海穴结合穴位埋线治疗脱肛26例[J].中国针灸，2021，41（3）：268.
[23] 殷晓晴，王洁，李海燕，等.水道穴按摩对产妇产后首次排尿的影响[J].中医药导报，2019，25（14）：92-94.
[24] 陈琳，安颂歌，魏方，等.艾灸联合耳穴压丸治疗乙型肝炎肝硬化肝肾阴虚型失眠的临床观察[J].中西医结合肝病杂志，2021，31（4）：349-351.
[25] 李紫明，陈坚义，孙爽，等.浅析天枢穴之枢机作用[J].中国针灸，2020，40（12）：53-55. |
|
|
|
